The Effects of Riluzole on Neurological, Brain Biochemical, and Histological Changes in Early and Late Term of Sepsis in Rats

Journal of Surgical Research

Volumn 152, Issue 2, 2009, Pages 238-248

  Toklu, Hale Z ^a   Uysal, Meral Keyer ^a   Kabasakal, Levent ^a   Sirvanci, Serap ^b   Ercan, Feriha ^b   Kaya, Mehmet ^c  

^a MARMARA UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

antioxidant; blood brain barrier; encephalopathy; glutamate; glutathione; MDA; neuroprotective; riluzole; sepsis

Indexed keywords

GLUTATHIONE; MALONALDEHYDE; RILUZOLE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BODY POSTURE; BRAIN CELL; BRAIN CORTEX; BRAIN EDEMA; BRAIN INJURY; BRAIN WATER; CELL INFILTRATION; CEREBELLUM; CLIMBING; CONSCIOUSNESS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FEVER; INFLAMMATORY CELL; LEUKOCYTE COUNT; LIPID PEROXIDATION; MALE; MUSCLE TONE; NERVE DEGENERATION; NEUROPROTECTION; NOCICEPTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; RECTUM TEMPERATURE; SEPSIS; SHAM PROCEDURE; SURVIVAL; TASK PERFORMANCE; WALKING; WEIGHT REDUCTION;

ANIMALS; BLOOD-BRAIN BARRIER; BODY TEMPERATURE; BRAIN; BRAIN EDEMA; BRAIN INJURIES; CELL MEMBRANE PERMEABILITY; FEMALE; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PAIN; PAIN MEASUREMENT; RATS; RATS, WISTAR; RILUZOLE; SEPSIS;

EID: 61849106500     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.03.013     Document Type: Article

References (54)

1. Weigand M.A., Horner C., Bardenheuer H.J., et al. The systemic inflammatory response syndrome. Best Pract Res Clin Anaesthesiol 18 (2004) 455
2. Neviere R.R., Ceepinskas G., Madorin W.S., et al. LPS pretreatment ameliorates peritonitis-induced myocardial inflammation and dysfunction: Role of myocytes. Am J Physiol 277 (1999) H885
3. Green R., Scott L.K., Minagar A., et al. Sepsis associated encephalopathy (SAE): A review. Front Biosci 9 (2004) 1637
4. Papadopoulos M.C., Davies D.C., Moss R.F., et al. Pathophysiology of septic encephalopathy: A review. Crit Care Med 28 (2000) 3019
5. Hendriks J.J., Teunissen C.E., de Vries H.E., et al. Macrophages and neurodegeneration. Brain Res Rev 48 (2005) 185
6. De Vries H.E., Kuiper J., De Boer A.G., et al. The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev, 49 (1997) 143
7. Volk T., and Kox W.J. Endothelium function in sepsis. Inflam Res 49 (2000) 185
8. Peters K., Unger R.E., Brunner J., et al. Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 60 (2003) 49
9. Brown G.C., and Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27 (2003) 325
10. Gilgun-Sherki Y., Melamed E., and Offen D. Oxidative stress induced-neurodegenerative diseases: The need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40 (2001) 959
11. Doble A. The pharmacology and mechanism of action of riluzole. Neurology 47 (1996) S233
12. Wahl F., Renou E., Mary V., et al. Riluzole reduces brain lesions and improves neurological function in rats after a traumatic brain injury. Brain Res 756 (1997) 247
13. Wahl F., and Stutzmann J.M. Neuroprotective effects of riluzole in neurotrauma models: A review. Acta Neurochir 73 Suppl (1999) 103
14. Bryson H.M., Fulton B., Benfield P., et al. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. Drugs 52 (1996) 549
15. Mohammadi B., Krampfl K., Moschref H., et al. Interaction of the neuroprotective drug riluzole with GABA(A) and glycine receptor channels. Eur J Pharmacol 415 (2001) 135
16. He Y., Benz A., Fur T., et al. Neuroprotective agent riluzole potentiates postsynaptic GABA(A) receptor function. Neuropharmacology 42 (2002) 199
17. Urenjak J., and Obrenovitch T.P. Pharmacological modulation of voltage-gated Na+ channels: A rational and effective strategy against ischemic brain damage. Pharmacol Rev 48 (1996) 21
18. Urenjak J., and Obrenovitch T.P. Pharmacological modulation of voltage-gated Na+ channels by riluzole: An alternative to antiexitotoxic actions. Rev Contemp Pharmacother 8 (1997) 237
19. Koh J.Y., Kim D.K., Hwang J.Y., et al. Antioxidative and proapoptotic effects of riluzole on cultured cortical neurons. J Neurochem 72 (1999) 716
20. Mu X., Azbill R.D., and Springer J.E. Riluzole improves measures of oxidative stress following traumatic spinal cord injury. Brain Res 870 (2000) 66
21. Storch A., Burkhardt K., Ludolph A.C., et al. Protective effects of riluzole on dopamine neurons: Involvement of oxidative stress and cellular energy metabolism. J Neurochem 75 (2000) 2259
22. Sener G., Toklu H., Ercan F., et al. Protective effect of β-glucan against oxidative organ injury in a rat model of sepsis. Int Immunopharmacol 5 (2005) 1387
23. Obrenovitch T.P., and Urenjak J. Actions of riluzole in animal models of CNS ischemia and trauma. Rev Contemp Pharmacother 8 (1997) 227
24. Kaya M., Palanduz A., Kalayci R., et al. Effects of lipopolysaccharide on the radiation-induced changes in the blood-brain barrier and the astrocytes. Brain Res 1019 (2004) 105
25. Bederson J.B., Pitts L.H., Tsuji M., et al. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurological examination. Stroke 17 (1986) 472
26. Ogan A. Bati{dotless}n içi sepsiste metilprednizolonun kan-beyin bariyeri geçirgenlik arti{dotless}sşi{dotless} ve nörolojik degǧerlendirme üzerine etkisi. Thesis, Istanbul University School of Medicine Department of Anestesiology and Reanimation. Adviser: Prof. Dr. Figen Esen. Thesis no: 124366 (2003), YOK Thesis Center
27. Beuge J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302
28. Beutler E. Glutathione. In: Beutler E. (Ed). Red blood cell metabolism-A manual of biochemical methods (1975), Grune and Stratton, New York 112-114
29. Durmaz R., Ertilav K., Akyuz F., et al. Lazaroid U-74389G attenuates edema in rat brain subjected to post-ischemic reperfusion injury. J Neurol Sci 215 (2003) 87
30. Singh J., and Gupta M.C. Effect of aspartate and glutamate on nociception, catalepsy, and core temperature in rats. Ind J Physiol Pharmacol 41 (1997) 123
31. Mariak Z., Lyson T., and Rudzinski W. Hypothermia as a neuroprotective agent. Pol J Neurol Neurosurg 38 (2004) 51
32. Riedel W., Lang U., Oetjen U., et al. Inhibition of oxygen radical formation by methylene blue, aspirin, or α-lipoic acid, prevents bacterial-lipopolysaccharide-induced fever. Mol Cell Biochem 247 (2003) 83
33. Hund E. Neurological complications of sepsis: Critical illness polyneuropathy and myopathy. J Neurol 248 (2001) 929
34. Bogdanski R., Blobner M., Becker I., et al. Cerebral histopathology following portal venous infusion of bacteria in a chronic porcine model. Anesthesiology 93 (2000) 793
35. Bogdanski R., Blobner M., and Werner C. Critical illness polyneuropathy and myopathy: Do they persist for lifetime?. Crit Care Med 31 (2003) 1279
36. McIntosh T.K., Smith D.H., Voddi M., et al. Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat. J Neurotrauma 13 (1996) 767
37. Kanthasamy A.G., Yun R.J., Nguyen B., et al. Effect of riluzole on the neurological and neuropathological changes in an animal model of cardiac arrest-induced movement disorder. J Pharmacol Exp Ther 288 (1999) 1340
38. Kogo J., Takeba Y., Kumai T., et al. Involvement of TNF-α in glutamate-induced apoptosis in a differentiated neuronal cell line. Brain Res 1122 (2006) 201
39. Figiel I., and Dzwonek K. TNF-α and TNF receptor 1 expression in the mixed neuronal-glial cultures of hippocampal dentate gyrus exposed to glutamate or trimethyltin. Brain Res 1131 (2007) 17
40. Wu G., Fang Y.Z., Yang S., et al. Glutathione metabolism and its implications for health. J Nutr 134 (2004) 489
41. Malmezat T., Breuille D., Capitan P., et al. Glutathione turnover is increased during the acute phase of sepsis in rats. J Nutr 130 (2000) 1239
42. Villa P., Saccani A., Sica A., et al. Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense. J Infect Dis 185 (2002) 1115
43. Noh K.M., Hwang J.Y., Shin H.C., et al. A novel neuroprotective mechanism of riluzole: Direct inhibition of protein kinase C. Neurobiol Dis 7 (2000) 375
44. Papadopoulos M.C., Lamb F.J., Moss R.F., et al. Fecal peritonitis causes edema and neuronal injury in pig cerebral cortex. Clin Sci (London) 96 (1999) 461
45. Kaptanoglu E., Okutan O., Akbiyik F., et al. Correlation of injury severity and tissue Evans blue content, lipid peroxidation, and clinical evaluation in acute spinal cord injury in rats. J Clin Neurosci 11 (2004) 879
46. Tongren J.E., Yang C., Collins W.E., et al. Expression of proinflammatory cytokines in four regions of the brain in Macaque mulatta (Rhesus) monkeys infected with Plasmodium coatneyi. Am J Trop Med Hyg 62 (2000) 530
47. Barichello T., Fortunato J.J., Vitali A.M., et al. Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation. Crit Care Med 34 (2006) 886
48. Mizuta I., Ohta M., Ohta K., et al. Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes. Neurosci Lett 310 (2001) 117
49. Janis L.S., and Stein D.G. Intraseptal injections of NGF attenuates edema formation following septal lesions in the rat. Neurosci Lett 214 (1996) 21
50. Kempski O. Cerebral edema. Semin Nephrol 21 (2001) 303
51. Unterberg A.W., Stover J., Kress B., et al. Edema and brain trauma. Neuroscience 129 (2004) 1021
52. Obrenovitch T.P. Neuroprotective strategies: Voltage-gated Na+ channel down-modulation versus presynaptic glutamate release inhibition. Rev Neurosci 9 (1998) 203
53. Zona C., Siniscalchi A., Mercuri N.B., et al. Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons. Neuroscience 85 (1998) 931
54. Mantz J., Chéramy A., Thierry A.M., et al. Anesthetic properties of riluzole (54274 RP), a new inhibitor of glutamate neurotransmission. Anesthesiology 76 (1992) 844